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Aim Although the efficacy of cardiac pacing in patients with neurally mediated syncope (NMS) and documented asystole is
established, a more robust point estimate of the benefit, which is not possible with any individual study, is lacking.
...................................................................................................................................................................................................
Methods
and results
We undertook a meta-analysis of individual participant data from four studies that reported follow-up data on syncope
recurrence with cardiac pacing in patients with NMS who had had an electrocardiographic (ECG) documentation of an
asystolic event by means of implantable loop recorder (ILR). Of a total of 1046 patients, who had ILR implanted, 383
(36.6%) patients had an ECG documentation of a diagnostic event during mean follow-up of 13 ± 10 months. Of these,
201 (52%) patients, corresponding to 19.2% of the total ILRs, had an asystolic event of 12.8 ± 11.0 s duration docu-
mented and met the criteria for pacemaker therapy. Follow-up was available in 121 (60%) of those patients with asys-
tolic events. Syncope recurred after pacing in 18 (14.9%) patients with an actuarial rate of 13% [95% confidence interval
(CI) ±6] at 1 year, 21% (95%CI ±10) at 2 years, and 24% (95%CI ±11) at 3 years. On multivariable Cox regression anal-
ysis, positive tilt test response was the only significant predictor of syncope recurrence with a hazard ratio (95% CI) of
4.3 (1.4–13). On the contrary, type of asystolic event (sinus arrest or atrioventricular block), prodrome, cardiac abnor-
malities, number and duration of history of syncope, age, and gender were not predictors of recurrence of syncope.
...................................................................................................................................................................................................
Conclusion A long asystolic pause, suitable for pacemaker therapy, was found in one of five patients with ILR. After pacemaker
implantation, most of these patients remained free of syncope recurrence for up to 3 years. The benefit of pace-
maker was greater in patients with negative tilt test.
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Introduction
The diagnostic yield of implantable loop recorders (ILR) in patients
affected by certain or likely neurally mediated syncope (NMS) is well
established from several large studies in the literature performed in
the last two decades. Asystolic events accounted consistently in
these studies for about half of the diagnoses.1,2 Therefore, cardiac
pacing was the most frequent therapy prompted by ILR observations.
Less known is the outcome after pacemaker implantation due to
small number of such patients reported in individual studies. The
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efficacy of cardiac pacing in patients affected by NMS is debated due
to the risk of syncope recurrence favoured by hypotensive reflexes
(vasodepression) that are virtually always associated.3
We aimed to perform a meta-analysis of individual data from four
studies4–7 that recruited patients affected by certain or suspected
NMS, implanted (ILR), and reported follow-up data on syncope
recurrence after ILR-guided cardiac pacing to have a more robust
point estimate which is not possible with any individual study.
Methods
The four studies4–7 included in this meta-analysis were of patients
aged >_40 years affected by severe, recurrent, likely NMS. These stud-
ies were performed by the same group utilizing a rather homogene-
ous method for selection of patients, collection of data, and outcome
evaluation, thus allowing pooling of individual data from the original
databases of the four studies. This meta-analysis includes the vast
majority of patients with reflex syncope who have an available
follow-up after cardiac pacing. From a MedLine analysis of the litera-
ture, only one other study8 reported similar data in further 14
patients who had an asystolic event compatible with a reflex mecha-
nism and received a pacemaker. Lacking individual data, these patients
could not be included in analysis, but the results of that study are
discussed in the Discussion.
In accordance with the guidelines of the European Society of
Cardiology (ESC),1 NMS was considered likely when the clinical fea-
tures were consistent with a reflex mechanism and competing diag-
noses had been excluded. Specifically, exclusion criteria were the
following: (i) suspected cardiac arrhythmic syncope [inadequate sinus
bradycardia (<50 b.p.m.) or sinoatrial block, second-degree Mobitz I
atrioventricular (AV) block, second-degree Mobitz II or third-degree
AV block, paroxysmal tachyarrhythmia or ventricular tachycardia,
and bundle branch block]; (ii) severe structural heart disease and/or
significant electrocardiographic (ECG) abnormalities; (iii) orthostatic
hypotension; and (iv) non-syncopal causes of transient loss of con-
sciousness. Moreover, patients with (v) reflex syncopes due to rever-
sible causes (e.g. vasoactive drugs, concomitant diseases, etc.) were
excluded.
An asystolic syncope >3 s or non-syncopal asystole >6 s recorded
by ILR was considered compatible with a likely reflex mechanism
when it was part of a self-terminating short episode characterized by:
(i) sinus arrest—progressive sinus bradycardia or initial sinus tachy-
cardia followed by progressive sinus bradycardia until sinus arrest; (ii)
sinus bradycardia plus AV block—progressive sinus bradycardia fol-
lowed by AV block (and ventricular pause/s) with concomitant
decrease in sinus rate; (iii) AV block—sudden onset AV block (and
ventricular pause/s) with constant P-P cycle implying no rise in sinus
rate in response to ventricular arrest or bradycardia. These patients
were candidates to receive a dual-chamber pacemaker with rate hys-
teresis, and those patients with an available follow-up after pace-
maker implant were included for analysis (Figure 1).
Conversely, the following findings did not confirm NMS and sug-
gested an intrinsic asystolic event: (i) sinus arrest at the end of parox-
ysmal atrial fibrillation, i.e. brady–tachy form of sick sinus syndrome
and (ii) asystolic events followed by persistent bradycardia or AV
block. These patients were not included in the analysis.
Statistical analysis
The raw data of individual patients enrolled in four studies4–7 were
pooled in a unique database that was available for this meta-analysis.
Continuous data were presented as mean ± standard deviation or
median (interquartile range), as appropriate, whereas categorical
data were presented as absolute and relative frequencies. The
Kolmogorov–Smirnov method was used to check the normality of
distribution. Continuous variables were compared using the t-test or
a non-parametric Mann–Whitney test. The Fisher’s exact test was
used to compare proportions. The time to the first syncope recur-
rence was analysed by means of the Kaplan–Meier survival curves,
which were compared using the log-rank test. The stepwise Cox pro-
portional hazards regression allowed analysing the effect of several
Figure 1 Cumulative data of ILR patients included in this meta-
analysis. F.U., follow-up.
What’s new?
• By means of a meta-analysis of individual patient data from
four studies performed in patients with asystolic reflex syn-
cope documented by implantable loop recorder, we had a
more robust point estimate of the benefit of cardiac pacing
which was not possible with any individual study.
• We estimated that, after pacemaker implantation, 65–87% of
these patients will remain free of syncope recurrence for up
to 3 years. Further research is very unlikely to change the con-
fidence in the estimate of effect.
• We estimated that patients with negative tilt test will have
<6% risk of syncope recurrence within 3 years. This rate is
similar to that observed in patients paced for intrinsic atrioven-
tricular block.
• On the contrary, the patients with positive tilt test will have a
higher risk of recurrence of syncope with a large confidence
range of 13–53% which makes any estimate of the benefit of
pacing uncertain. Further research is warranted.
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D
ow
nloaded from
 https://academ
ic.oup.com
/europace/article-abstract/20/8/1362/4753707 by Biblioteca di Scienze tecnologiche user on 28 D
ecem
ber 2018
risk factors on syncopal recurrence. Analyses were performed using
the MedCalc version 15.8 (Med Calc Software, Mariakerke, Belgium).
Results
The baseline characteristics of the patients and their ILR findings are
presented in Table 1.
Of a total of 1046 patients who had ILR implantation, 383 (36.6%)
patients had an ECG documentation of a diagnostic event during a
mean follow-up of 13 ± 10 months with an actuarial estimate of 52%
[95% confidence interval (CI) 46–58] at 36 months. Of these, 201
(52%) patients, corresponding to 19.2% of total ILRs, had a documen-
tation of an asystolic event of 12.8 ± 11.0 s duration (symptomatic in
184 patients and asymptomatic in 17 patients) compatible with a
reflex mechanism and met the criteria for pacemaker therapy (Figures
1 and 2). Follow-up after pacing was available in 121 (60%) of these
patients with asystolic events. In the other 80 patients, follow-up data
were unavailable (n= 41) or they did not receive an active pacemaker
because they were randomized to pacemaker off arm (n= 39).
Outcome after cardiac pacing
Syncope recurred after pacing in 18 of 121 (14.9%) patients with an
actuarial rate of 13% (95% CI ±6) at 1 year, 21% (95%CI ±10) at
....................................................................................................................................................................................................................
Table 1 Baseline characteristics of the total population of patients receiving ILR and of patients with asystolic NMS
documented by ILR who received an active pacemaker and of those who did not
Characteristics ILR, all (n5 1046) ILR, asystole (n5 201) PM (n5 121) No PM (n5 80)
Age (years), mean (SD) 66 (13) 66 (13) 66 (14) 66 (13)
Male gender, n (%) 474 (45) 89 (44) 54 (44) 35 (44)
Syncope events
Total events, median (IQR) 5 (4–10) 6 (4–10) 5 (4–10) 6 (4–10)
Events in the last 2 years, median (IQR) 4 (3–5) 4 (3–5) 4 (3–5) 4 (3–5)
Age at first syncope (years), mean (SD) 53 (21) 53 (21) 55 (21) 50 (21)
Without prodrome, n (%) 635 (61) 132 (66) 80 (66) 52 (66)
Any ECG or structural cardiac abnormality, n (%) 132 (13) 19 (9) 10 (8) 9 (11)
Tilt test, performed, n (%) 928 (89) 165 (82) 97 (80) 68 (85)
Any positive response 438 (47) 81 (49) 45 (46) 36 (53)
Asystolic response >_3 s 100 (11)* 30 (18)* 16 (16) 14 (21)
ILR findings
Mean duration of follow-up (months), mean (SD) 13 (10) – 14 (9) –
Asystole classification, n (%)
Sinus arrest – 105 (52) 58 (48) 47 (59)
Sinus bradyþAV block – 23 (11) 12 (10) 11 (14)
AV block – 41 (20) 26 (21) 15 (19)
Undefined – 32 (16) 26 (21) 6 (8)
Asystole duration (s), mean (SD), s – 12 (10) 11 (8) 12 (11)
AV, atrioventricular; ECG, electrocardiogram; ILR, implantable loop recorder; IQR, interquartile range; PM, pacemaker; SD, standard deviation.
*P= 0.001.
Figure 2 Overall ECG diagnoses during ILR observations. An asystolic pause compatible with a reflex mechanism accounted for 52% of diagnoses.
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2 years, and 24% (95%CI ±11) at 3 years (Figure 3). On multivariable
Cox regression analysis, positive tilt test response was the only signifi-
cant predictor of syncopal recurrence with a hazard ratio of 4.3 (95%
CI 1.4–13); on the contrary, type of asystolic event (sinus arrest or
AV block), prodrome, cardiac abnormalities, number and duration of
history of syncope, age, and gender were not predictors of recur-
rence of syncope. No heterogeneity between studies was present.
At 3 years, syncope recurred in 1 (2%) tilt-negative patient
(95%CI ±4%) and in 10 (33%) tilt-positive patients (95%CI ±20%)
(Figure 4): 7 of these patients had had a mixed/vasodepressor
response and 3 patients a cardioinhibitory response during the index
tilt test. The clinical characteristics of tilt-positive and tilt-negative
patients were similar (Table 2). When tilt testing was removed from
the model, the total number of syncope episodes during life was pre-
dictive of syncope recurrence after cardiac pacing [hazard ratio 1.04
(95% CI 1.01–1.07)].
Discussion
A long asystolic pause of likely reflex origin suitable for pacemaker
therapy was found in 19.2% of patients who had received an ILR. This
rate is slightly higher than the rate of 16% found by Farwell et al.9 and
15% found by Edvardsson et al.10 in patients with unexplained syn-
cope after initial workup (cardiac syncope unlikely). After pacemaker
implantation, 76% (95% CI 65–87%) of these patients remained free
of syncope recurrence for up to 3 years. This meta-analysis provides
a more robust point estimate, which was not possible with any indi-
vidual previous study. Further research is very unlikely to change our
confidence in the estimate of effect.
Despite NMS is a common disease, this relatively small meta-
analysis included most of the studies available in literature concerning
paced patients for ILR-documented asystolic NMS. Sud et al.,8 among
a heterogeneous population of 122 patients who had received an
ILR, found further 14 patients who had an asystolic event compatible
with a reflex mechanism (sinus arrest or sinus arrest plus AV block)
and received a pacemaker; of these, 6 (42%) patients had syncope
recurrence after a median of 4.7 years, but syncope burden was very
low and decreased from 2.17 per year before to 0.45 per year after
pacing. In the Syncope Unit Project 2 (SUP 2) study,11 we also
observed a similar decrease of the syncope burden from 1.9 in the
year before to 0.13 in the year after pacemaker implantation.
The benefit of a pacemaker was greater in patients with negative tilt
test. The observed 2% recurrence rate at 36 months with pacing and
its tight upper confidence interval of 6% show a benefit similar to that
observed in patients paced for intrinsic AV block.12,13 Thus, pacemaker
therapy can be offered to these patients with the same confidence as it
can in patients with intrinsic cardiac AV block. Further research is very
unlikely to change our confidence in the estimate of this effect.
Figure 3 Recurrence rate of syncope after pacemaker
implantation.
P
Figure 4 Recurrence rate of syncope after pacemaker implanta-
tion in patients with positive and negative tilt test response.
.................................................................................................
Table 2 Comparison between paced patients who had
a positive or a negative response during tilt test
Characteristics Tilt positive
(n5 45)
Tilt negative
(n5 52)
P-value
Age (years), mean (SD) 64 (10) 65 (13) 0.8
Male gender, n (%) 19 (42) 27 (52) 0.4
Syncope events
Total events, median (IQR) 6 (4–10) 4.5 (4–6) 0.5
Events in the last 2 years,
median (IQR)
3 (3–5) 4 (3–5) 0.8
Age at first syncope
(years), mean (SD)
50 (22) 56 (20) 0.2
Without prodrome, n (%) 26 (58) 35 (67) 0.4
Any ECG or structural
cardiac abnormality, n (%)
4 (9) 2 (4) 0.4
ILR findings: asystole classification, n (%)
Sinus arrest 17 (38) 30 (58) 0.7
Sinus bradyþAV block 5 (11) 5 (10) 1.0
AV block 10 (22) 9 (17) 0.6
Undefined 13 (29) 8 (15) 0.14
AV, atrioventricular; ECG, electrocardiogram; ILR, implantable loop recorder;
IQR, interquartile range; PM, pacemaker; SD, standard deviation.
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On the contrary, the benefit was less in patients with a positive tilt
test. One-third of these patients will have a recurrence of syncope dur-
ing the following 3 years although some benefit may still accrue in
terms of reduced syncope burden. Due to the large confidence interval
with an estimate of recurrence at 3 years ranging from 13% to 53%, no
definite conclusion can be made regarding the effect of cardiac pacing
in this subgroup of patients. Further research is very likely to have an
important impact on our confidence in the estimate of effect and is
likely to change the present estimate. No other factor, except positive
tilt testing, was able to predict the recurrence of syncope. Patients with
positive and negative tests had similar baseline characteristics and simi-
lar ECG patterns when an episode was documented by ILR, which
make them indistinguishable from each other. This finding supports the
hypothesis that tilt testing is a useful tool for distinguishing patients
with an isolated cardioinhibitory reflex from those with an associated
hypotensive susceptibility that may play an additive role in causing syn-
cope. Patients should be informed that they might have some recur-
rence of syncope, despite cardiac pacing. Since, in these patients, the
neurally mediated reflex is both vasodilation and bradycardia, antihypo-
tensive measures should be added to cardiac pacing, such as, e.g. dis-
continuation/reduction of antihypertensive therapy14 or addition of
midodrine1 or fludrocortisone.15 However, implementation of meth-
ods for a better discrimination of the relative role of cardioinhibition
and vasodepression in causing syncope are warranted and will be the
objective of future studies.
Limitations
The diagnosis of NMS was presumptive based on clinical features and
exclusion of competing diagnoses, i.e. intrinsic cardiac pauses, accord-
ing to the current ESC guidelines.1 We cannot exclude that an undiag-
nosed intrinsic sinoatrial or AV conduction abnormality might have
played a role in causing an asystolic pause in a few tilt-negative patients.
We previously showed that this happened in 13% of cases.16 Such a
circumstance seems unlikely in most patients included in this meta-
analysis. Indeed, as per protocol, we identified and excluded from anal-
ysis the patients with ILR features suggesting an intrinsic conduction
abnormality. Moreover, the clinical features of tilt-negative patients
were indistinguishable from those of tilt-positive patients who are
more likely to be affected by neutrally mediated syncope.
Conclusion
One out of five patients aged >_40 years affected by severe, recurrent,
likely NMS had the documentation of an asystolic pause by means of
ILR. After pacemaker implantation, most of these patients remained
free of syncope recurrence for up to 3 years. The benefit of
pacemaker was greater in patients with negative tilt test who had a
low recurrence rate as that observed in patients with intrinsic AV
block. On the contrary, owing to the large confidence interval, the
estimate of benefit was uncertain in patients with positive tilt test.
Conflict of interest: R.S. is a consultant to Medtronic Inc. and a
member of the speakers’ bureau of Abbott Inc. (St. Jude Medical).
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